Amicogen, Inc. (092040.KQ)
KRW 3930.0
(-3.2%)
KRW 3930.0
(-3.2%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 46.83 Billion KRW | 1.96% |
| 2022 | 45.93 Billion KRW | 18.67% |
| 2021 | 38.71 Billion KRW | 9.62% |
| 2020 | 35.31 Billion KRW | 5.84% |
| 2019 | 33.36 Billion KRW | -0.99% |
| 2018 | 33.69 Billion KRW | 26.27% |
| 2017 | 26.68 Billion KRW | 42.62% |
| 2016 | 18.71 Billion KRW | -34.7% |
| 2015 | 28.65 Billion KRW | 972.93% |
| 2014 | 2.67 Billion KRW | 73.33% |
| 2013 | 1.54 Billion KRW | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 49.19 Billion KRW | -3.15% |
| 2024 Q1 | 50.79 Billion KRW | 8.45% |
| 2023 Q4 | 46.83 Billion KRW | -4.61% |
| 2023 FY | 46.83 Billion KRW | 1.96% |
| 2023 Q1 | 46.08 Billion KRW | 0.33% |
| 2023 Q2 | 49.42 Billion KRW | 7.24% |
| 2023 Q3 | 49.09 Billion KRW | -0.66% |
| 2022 Q2 | 47.08 Billion KRW | 12.78% |
| 2022 Q3 | 50.93 Billion KRW | 8.18% |
| 2022 FY | 45.93 Billion KRW | 18.67% |
| 2022 Q1 | 41.75 Billion KRW | 7.86% |
| 2022 Q4 | 45.93 Billion KRW | -9.82% |
| 2021 Q2 | 36.56 Billion KRW | 12.35% |
| 2021 Q4 | 38.71 Billion KRW | 9.08% |
| 2021 Q3 | 35.48 Billion KRW | -2.94% |
| 2021 FY | 38.71 Billion KRW | 9.62% |
| 2021 Q1 | 32.54 Billion KRW | -7.84% |
| 2020 Q2 | 35.81 Billion KRW | 3.16% |
| 2020 Q3 | 35.44 Billion KRW | -1.02% |
| 2020 FY | 35.31 Billion KRW | 5.84% |
| 2020 Q1 | 34.71 Billion KRW | 4.05% |
| 2020 Q4 | 35.31 Billion KRW | -0.38% |
| 2019 Q3 | 38.32 Billion KRW | 5.54% |
| 2019 Q2 | 36.31 Billion KRW | -0.4% |
| 2019 Q1 | 36.46 Billion KRW | 8.21% |
| 2019 FY | 33.36 Billion KRW | -0.99% |
| 2019 Q4 | 33.36 Billion KRW | -12.95% |
| 2018 Q4 | 33.69 Billion KRW | 2.75% |
| 2018 Q2 | 33.74 Billion KRW | 26.38% |
| 2018 Q1 | 26.69 Billion KRW | 0.04% |
| 2018 FY | 33.69 Billion KRW | 26.27% |
| 2018 Q3 | 32.79 Billion KRW | -2.81% |
| 2017 Q3 | 26.08 Billion KRW | 13.79% |
| 2017 Q4 | 26.68 Billion KRW | 2.31% |
| 2017 FY | 26.68 Billion KRW | 42.62% |
| 2017 Q1 | 20.36 Billion KRW | 8.82% |
| 2017 Q2 | 22.92 Billion KRW | 12.58% |
| 2016 Q1 | 26.86 Billion KRW | -6.24% |
| 2016 FY | 18.71 Billion KRW | -34.7% |
| 2016 Q4 | 18.71 Billion KRW | -13.85% |
| 2016 Q3 | 21.71 Billion KRW | -13.16% |
| 2016 Q2 | 25 Billion KRW | -6.92% |
| 2015 Q3 | 30.94 Billion KRW | 545.63% |
| 2015 Q2 | 4.79 Billion KRW | 106.18% |
| 2015 Q1 | 2.32 Billion KRW | -12.97% |
| 2015 FY | 28.65 Billion KRW | 972.93% |
| 2015 Q4 | 28.65 Billion KRW | -7.38% |
| 2014 FY | 2.67 Billion KRW | 73.33% |
| 2014 Q4 | 2.67 Billion KRW | 47.02% |
| 2014 Q2 | 1.89 Billion KRW | 2.51% |
| 2014 Q1 | 1.84 Billion KRW | 19.87% |
| 2014 Q3 | 1.81 Billion KRW | -4.05% |
| 2013 FY | 1.54 Billion KRW | 0.0% |
| 2013 Q3 | 2.42 Billion KRW | 0.0% |
| 2013 Q4 | 1.54 Billion KRW | -36.46% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| HLB Co., Ltd. | 11.42 Billion KRW | -310.082% |
| iNtRON Biotechnology, Inc. | 1.01 Billion KRW | -4532.328% |
| BINEX Co., Ltd. | 28.26 Billion KRW | -65.73% |
| Bioneer Corporation | 41.35 Billion KRW | -13.26% |
| Anterogen.Co.,Ltd. | 1.91 Billion KRW | -2351.585% |
| MEDIPOST Co., Ltd. | 14.51 Billion KRW | -222.642% |
| CrystalGenomics, Inc. | 1.55 Billion USD | -2912.472% |
| Helixmith Co., Ltd | 914.11 Million KRW | -5023.832% |
| Chabiotech Co.,Ltd. | 34.11 Billion KRW | -37.287% |
| Medy-Tox Inc. | 59.61 Billion KRW | 21.437% |
| Peptron, Inc. | 172.18 Million KRW | -27101.572% |
| Genexine, Inc. | 3.8 Billion KRW | -1130.325% |
| HLB Therapeutics Co.,Ltd. | 5.33 Billion KRW | -777.797% |
| LegoChem Biosciences, Inc. | 196.83 Million KRW | -23695.47% |
| ALTEOGEN Inc. | 1.06 Billion KRW | -4284.075% |
| PharmaResearch Co., Ltd. | 50.23 Billion KRW | 6.758% |
| SillaJen, Inc. | 1.21 Billion KRW | -3762.503% |
| JETEMA, Co., Ltd. | 12.74 Billion KRW | -267.616% |
| OliX Pharmaceuticals,Inc | 468.4 Million KRW | -9899.305% |
| Genomictree Inc. | 496.53 Million KRW | -9332.972% |
| MedPacto, Inc. | 620.00 KRW | -7554462558.71% |
| D&D Pharmatech | 3.45 Billion KRW | -1257.527% |
| EASY BIO,Inc. | 25.93 Billion KRW | -80.571% |
| GI Innovation, Inc. | - KRW | -Infinity% |